Attention deficit hyperactivity disorder and Drug withdrawal syndrome neonatal

Summary:

Drug withdrawal syndrome neonatal is found among people with Attention deficit hyperactivity disorder, especially for people who are male, 0-1 old.

The study analyzes which people have Drug withdrawal syndrome neonatal with Attention deficit hyperactivity disorder. It is created by eHealthMe based on reports of 15 people who have Attention deficit hyperactivity disorder from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Attention deficit hyperactivity disorder?

Attention deficit hyperactivity disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness) is found to be associated with 609 drugs and 1,393 conditions by eHealthMe. Check the latest studies of Attention deficit hyperactivity disorder.

What is Drug withdrawal syndrome neonatal?

Drug withdrawal syndrome neonatal (prenatal nas is caused by discontinuation of drugs taken by the pregnant mother) is found to be associated with 254 drugs and 371 conditions by eHealthMe. Check the latest studies of Drug withdrawal syndrome neonatal.

On Jul, 19, 2026

15 people who have Attention Deficit Hyperactivity Disorder and Drug Withdrawal Syndrome Neonatal are studied.

Would you have Drug withdrawal syndrome neonatal when you have Attention deficit hyperactivity disorder?

Gender of people who have Attention Deficit Hyperactivity Disorder and experienced Drug Withdrawal Syndrome Neonatal *:

female: 27.27 %
male: 72.73 %

Age of people who have Attention Deficit Hyperactivity Disorder and experienced Drug Withdrawal Syndrome Neonatal *:

Common co-existing conditions for these people *:

Drug Dependence: 6 people, 40.00%
Depression: 5 people, 33.33%
Stress And Anxiety: 3 people, 20.00%
Bipolar Disorder (mood disorder): 2 people, 13.33%
Sleep Disorder: 1 person, 6.67%
Birth Control: 1 person, 6.67%
Borderline Personality Disorder: 1 person, 6.67%
Constipation: 1 person, 6.67%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 1 person, 6.67%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 6.67%

Common drugs taken by these people *:

Suboxone: 4 people, 26.67%
Adderall: 3 people, 20.00%
Nicotine: 2 people, 13.33%
Concerta: 2 people, 13.33%
Seroquel: 2 people, 13.33%
Sertraline: 2 people, 13.33%
Seroquel Xr: 2 people, 13.33%
Subutex: 2 people, 13.33%
Vyvanse: 2 people, 13.33%
Benazepril Hydrochloride: 1 person, 6.67%

Common symptoms for these people *:

Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 10 people, 66.67%
Constipation: 2 people, 13.33%
Weakness: 1 person, 6.67%
High-Pitched Crying: 1 person, 6.67%
Abnormal Behavior: 1 person, 6.67%
Angioedema (rapid swelling of the dermis): 1 person, 6.67%
Blood Immunoglobulin E Increased: 1 person, 6.67%
Breech Presentation: 1 person, 6.67%
Convulsion Neonatal (muscle contraction and relaxation rapidly in neonate): 1 person, 6.67%
Depressed Level Of Consciousness: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Drug withdrawal syndrome neonatal?

- Check whether Drug withdrawal syndrome neonatal is associated with a drug or a condition

Related publications that referenced our studies

Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Drug withdrawal syndrome neonatal and Attention deficit hyperactivity disorder, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.